Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups

Area of Science:

• Oncology
• Virology
• Cell Biology

Background:

• Nasopharyngeal carcinoma (NPC) is a metastatic cancer linked to Epstein-Barr virus (EBV).
• Detached cancer cells must survive anoikis (apoptosis due to detachment) to metastasize.
• Latent membrane protein 1 (LMP1), an EBV-encoded oncogenic protein, plays a role in NPC.

Purpose of the Study:

• To investigate if LMP1 expression enables epithelial cells to recover from anoikis.
• To characterize the mechanisms and strain-specific properties of LMP1 in anoikis recovery.
• To evaluate the role of LMP1 in the metastatic potential of NPC cells.

Main Methods:

• A modified anoikis assay was employed to assess cell survival, reattachment, and outgrowth.
• Expression of wild-type and mutant LMP1, as well as different LMP1 strains, in NPC cells (HK1).
• Analysis of Akt signaling pathway activation and the importance of LMP1's C-terminal activation regions (CTARs).

Main Results:

• LMP1 expression promoted the outgrowth of HK1 NPC cells following anoikis induction.
• This outgrowth was independent of enhanced survival in suspension or improved reattachment.
• LMP1-mediated outgrowth required Akt signaling via its PXQXT motif and all three CTARs; specific LMP1 strains (B958, China1, Med+) conferred this ability.

Conclusions:

• LMP1 facilitates NPC cell recovery from anoikis, contributing to metastatic potential.
• The mechanism involves Akt signaling and is dependent on specific LMP1 strain sequences.
• LMP1 strain diversity offers insights into NPC metastasis and potential sequence-associated risk factors.